Geode Capital Management LLC Boosts Holdings in PetMed Express, Inc. (NASDAQ:PETS)

Geode Capital Management LLC raised its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 1.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 224,788 shares of the company’s stock after acquiring an additional 3,558 shares during the quarter. Geode Capital Management LLC owned 1.09% of PetMed Express worth $1,084,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Arrowstreet Capital Limited Partnership lifted its holdings in PetMed Express by 26.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 513,381 shares of the company’s stock valued at $2,474,000 after acquiring an additional 107,614 shares during the period. JPMorgan Chase & Co. lifted its holdings in PetMed Express by 355.5% in the fourth quarter. JPMorgan Chase & Co. now owns 106,954 shares of the company’s stock valued at $516,000 after acquiring an additional 83,473 shares during the period. American Century Companies Inc. lifted its holdings in PetMed Express by 15.3% in the fourth quarter. American Century Companies Inc. now owns 33,662 shares of the company’s stock valued at $162,000 after acquiring an additional 4,459 shares during the period. Blair William & Co. IL lifted its holdings in PetMed Express by 95.2% in the fourth quarter. Blair William & Co. IL now owns 20,300 shares of the company’s stock valued at $98,000 after acquiring an additional 9,900 shares during the period. Finally, Diametric Capital LP acquired a new stake in PetMed Express in the fourth quarter valued at $86,000. Institutional investors and hedge funds own 73.33% of the company’s stock.

PetMed Express Stock Down 1.7 %

NASDAQ:PETS opened at $3.38 on Thursday. The company has a market capitalization of $69.82 million, a PE ratio of 338.34 and a beta of 0.99. PetMed Express, Inc. has a 52-week low of $2.90 and a 52-week high of $6.85. The stock has a fifty day simple moving average of $3.76 and a 200-day simple moving average of $4.45.

PetMed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, February 10th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a return on equity of 0.37% and a net margin of 0.14%. As a group, equities analysts anticipate that PetMed Express, Inc. will post 0.19 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Morgan Stanley cut their price target on PetMed Express from $3.50 to $3.20 and set an “underweight” rating for the company in a research note on Thursday, April 17th. StockNews.com downgraded PetMed Express from a “buy” rating to a “hold” rating in a research note on Wednesday, April 23rd.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.